Drug Trial Radar · NCT07232719
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Nov 17, 2025
Primary completion
Jun 2027
Study completion Jun 2028
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of retatrutide compared with placebo for body weight reduction. Participation in the study will last about 65 weeks and may include about 18 visits. Participants who complete the primary 56-week GZQJ study will have the opportunity to receive an additional 52 weeks of treatment with retatrutide.
Conditions
- Obesity
- Overweight
Interventions
RetatrutideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Body WeightTime frame: Baseline, Week 56
Locations
31 sites in 2 countries. Site status is shown where the registry gives one.
Artemis Institute for Clinical Research
Riverside, California
JEM Research Institute
Atlantis, Florida
Headlands Research Orlando
Orlando, Florida
Care Access - Tamarac
Tamarac, Florida
Care Access - Arlington Heights
Arlington Heights, Illinois
L-MARC Research Center
Louisville, Kentucky
IMA Clinical Research Monroe - Armand
Monroe, Louisiana
Pharmasite Research, Inc.
Baltimore, Maryland
Clinical Research Professionals
Chesterfield, Missouri
Clinvest Headlands Llc
Springfield, Missouri
IMA Clinical Research Warren
Warren Township, New Jersey
IMA Clinical Research Manhattan
New York, New York
Trial Management Associates - Wilmington - Floral Parkway
Wilmington, North Carolina
Cedar Health Research
Dallas, Texas
Headlands Research-El Paso
El Paso, Texas
Cedar Health Research - Euless
Euless, Texas
Cedar Health Research - Fort Worth
Fort Worth, Texas
Care Access - Houston
Houston, Texas
IMA Clinical Research San Antonio
San Antonio, Texas
FutureMeds - Birmingham
Birmingham, United Kingdom
Layton Medical Centre
Blackpool, United Kingdom
Bradford on Avon Health Centre
Bradford on Avon, United Kingdom
FutureMeds - Liverpool
Bromborough, United Kingdom
Cheadle Community Hospital
Cheadle, United Kingdom
HMC Health Group - Meadows Centre for Health
Hounslow, United Kingdom
St Bartholomew's Medical Centre
Oxford, United Kingdom
Atlantic Medical
Penzance, United Kingdom
The Adam Practice
Poole, United Kingdom
Woodstock Bower Surgery
Rotherham, United Kingdom
Rame Group Practice
Torpoint, United Kingdom
Albany House Medical Centre
Wellingborough, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.